Ljungberg T, Ungerstedt U
Pharmacol Biochem Behav. 1985 Sep;23(3):479-85. doi: 10.1016/0091-3057(85)90025-5.
A simple and rapid screening method, where the ability of neuroleptic drugs to antagonise the abnormal pattern of exploration induced by a low dose of d-amphetamine in a 10 min test, was evaluated. The d-amphetamine 2 mg/kg pretreatment induced both an increased locomotion, thought to reflect an increased dopamine transmission in the nucleus accumbens, and weak stereotypies, thought to reflect an increased dopamine transmission in the neostriatum. Haloperidol, chlorpromazine and thioridazine blocked all ongoing behaviours while clozapine and sulpiride, regarded as causing less extrapyramidal side effects in the clinic, only antagonised the d-amphetamine induced locomotion. The findings support the notion that the common site of action for anti-psychotic drugs is blockade of dopamine receptors outside the neostriatum while the blockade of dopamine receptors within the striatum probably are related to the propensity of these drugs to induce the extrapyramidal side effects. It seems possible with this method to screen neuroleptic drugs for their relative potency in blocking limbic and striatal dopamine receptors simultaneously in one short experiment. The method might be used when new anti-psychotic drugs with low incidences of extrapyramidal side effects are sought for.
评估了一种简单快速的筛选方法,该方法通过10分钟的测试,检测抗精神病药物拮抗低剂量右旋苯丙胺诱导的异常探索模式的能力。2mg/kg的右旋苯丙胺预处理会导致运动增加,这被认为反映了伏隔核中多巴胺传递增加,还会导致轻微刻板行为,这被认为反映了新纹状体中多巴胺传递增加。氟哌啶醇、氯丙嗪和硫利达嗪会阻断所有正在进行的行为,而氯氮平和舒必利在临床上被认为引起较少的锥体外系副作用,它们仅拮抗右旋苯丙胺诱导的运动。这些发现支持了以下观点:抗精神病药物的共同作用部位是阻断新纹状体以外的多巴胺受体,而阻断纹状体内的多巴胺受体可能与这些药物诱发锥体外系副作用的倾向有关。通过这种方法,似乎有可能在一个简短的实验中同时筛选抗精神病药物阻断边缘系统和纹状体多巴胺受体的相对效力。当寻找锥体外系副作用发生率低的新型抗精神病药物时,该方法可能会被采用。